Blidarvetug is a veterinary monoclonal antibody targeting MS4A1/CD20, which can be used to study CD20-positive B-cell lymphoma in dogs.
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025
References:
[1]. WHO Drug Information, Vol. 39, No. 4, 2025
















